FBXO32 and sarcopenia: This promotes the activation of the FoxO transcription factor, increasing the expression of muscle-specific E3 ubiquitin ligases Atrogin-1 and MuRF1, which in turn promote muscle protein degradation, exacerbating sarcopenia [20,21].